AstraZeneca’s breast cancer drug combination fails in late-stage trial EP News Bureau Jun 19, 2024 The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Gilead gets US FDA nod for Trodelvy to treat metastatic triple-negative breast cancer EP News Bureau Apr 8, 2021 Trodelvy significantly reduced the risk of death by 49 per cent compared with single-agent chemotherapy in the Phase 3 ASCENT…
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast… EP News Bureau Apr 8, 2020 Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and…
